Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1994 Jun;82(2):306–313.

Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo.

M Haak-Frendscho 1, K Robbins 1, R Lyon 1, R Shields 1, J Hooley 1, M Schoenhoff 1, P Jardieu 1
PMCID: PMC1414812  PMID: 7927502

Abstract

High IgE responder BDF1 mice were immunized intraperitoneally (i.p.) with dinitrophenol4 (DNP4)-ovalbumin (OVA) in alum concomitant with intravenous (i.v.) administration of an anti-IgE monoclonal antibody (mAb). IgE levels were undetectable in mice treated with the anti-IgE antibody, whereas mice treated with isotype-matched irrelevant mAb had IgE levels comparable to that of untreated, immunized mice. Subsequent antigen challenges with DNP4-OVA, either at weekly or monthly intervals, failed to evoke an IgE response for greater than 2 months in mice treated with anti-IgE during the primary sensitization, even though the terminal half-life of the anti-IgE antibody was 7 days. This inhibition was specific for DNP4-OVA since the DNP4-OVA-suppressed mice were able to respond to keyhole limpet haemocyanin (KLH). To investigate the effects of antibody treatment at the cellular level, passive transfer experiments were performed. The primary DNP-specific IgE response of adoptive transfer recipient mice was the same whether the donor cells were from mice treated with IgG or anti-IgE. Transfer of enriched T- or B-cell populations indicated that T-cell help was not compromised by administration of the anti-IgE mAb. However, splenocytes from the anti-IgE-treated mice failed to synthesize IgE in vitro, and flow cytometric analysis of B cells from anti-IgE-treated mice showed a dose-dependent decrease in CD23+ cells following antibody treatment, which correlated with decreased serum IgE levels. Taken together, the results of these studies suggest that anti-IgE treatment suppresses IgE responses via effects on B cells rather than T cells, possibly through effects on CD23-dependent pathways.

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aubry J. P., Pochon S., Graber P., Jansen K. U., Bonnefoy J. Y. CD21 is a ligand for CD23 and regulates IgE production. Nature. 1992 Aug 6;358(6386):505–507. doi: 10.1038/358505a0. [DOI] [PubMed] [Google Scholar]
  2. Bach M. K., Brashler J. R. IgE antibody-specific abrogation of an established immune response in mice by modified antigens. J Immunol. 1975 Jun;114(6):1799–1807. [PubMed] [Google Scholar]
  3. Bazin H., Platteau B., Beckers A., Pauwels R. Differential effect of neonatal injections of anti-mu or anti-delta antibodies on the synthesis of IgM, IgD, IgE, IgA, IgG1, IgG2a, IgG2b, and IgG2c immunoglobulin classes. J Immunol. 1978 Nov;121(5):2083–2087. [PubMed] [Google Scholar]
  4. Bozelka B. E., McCants M. L., Salvaggio J. E., Lehrer S. B. IgE isotype suppression in anti-epsilon-treated mice. Immunology. 1982 Jul;46(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  5. Chen S. S. Genesis of host IgE competence: perinatal IgE tolerance induced by IgE processed and presented by IgE Fc receptor (CD23)-bearing B cells. Eur J Immunol. 1992 Feb;22(2):343–348. doi: 10.1002/eji.1830220209. [DOI] [PubMed] [Google Scholar]
  6. Chen S. S., Katz D. H. IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. J Exp Med. 1983 Feb 1;157(2):772–788. doi: 10.1084/jem.157.2.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen U., Scheuermann R. H., Wirth T., Gerster T., Roeder R. G., Harshman K., Berger C. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res. 1991 Nov 11;19(21):5981–5989. doi: 10.1093/nar/19.21.5981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Conrad D. H. Fc epsilon RII/CD23: the low affinity receptor for IgE. Annu Rev Immunol. 1990;8:623–645. doi: 10.1146/annurev.iy.08.040190.003203. [DOI] [PubMed] [Google Scholar]
  9. Dintzis H. M., Dintzis R. Z. Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1113–1117. doi: 10.1073/pnas.89.3.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Filion L. G., Lee W. Y., Sehon A. H. Suppression of the IgE antibody response to ovalbumin in mice with a conjugate of ovalbumin and isologous gamma-globulins. Cell Immunol. 1980 Aug 15;54(1):115–128. doi: 10.1016/0008-8749(80)90195-1. [DOI] [PubMed] [Google Scholar]
  11. Flores-Romo L., Shields J., Humbert Y., Graber P., Aubry J. P., Gauchat J. F., Ayala G., Allet B., Chavez M., Bazin H. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science. 1993 Aug 20;261(5124):1038–1041. doi: 10.1126/science.8351517. [DOI] [PubMed] [Google Scholar]
  12. Gause A., Yoshida N., Kappen C., Rajewsky K. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance. Eur J Immunol. 1987 Jul;17(7):981–990. doi: 10.1002/eji.1830170714. [DOI] [PubMed] [Google Scholar]
  13. Grenier-Brossette N., Bourget I., Akoundi C., Bonnefoy J. Y., Cousin J. L. Spontaneous and ligand-induced endocytosis of CD23 (Fc epsilon receptor II) from the surface of B lymphocytes generates a 16-kDa intracellular fragment. Eur J Immunol. 1992 Jun;22(6):1573–1577. doi: 10.1002/eji.1830220634. [DOI] [PubMed] [Google Scholar]
  14. Guy G. R., Gordon J. Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6239–6243. doi: 10.1073/pnas.84.17.6239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haak-Frendscho M., Ridgway J., Shields R., Robbins K., Gorman C., Jardieu P. Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo. J Immunol. 1993 Jul 1;151(1):351–358. [PubMed] [Google Scholar]
  16. Haba S., Nisonoff A. Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE. Proc Natl Acad Sci U S A. 1987 Jul;84(14):5009–5013. doi: 10.1073/pnas.84.14.5009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HayGlass K. T., Naides S. J., Benacerraf B., Sy M. S. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody. J Mol Cell Immunol. 1985;2(2):107–117. [PubMed] [Google Scholar]
  18. HayGlass K. T., Stefura W. Isotype-selective abrogation of established IgE responses. Clin Exp Immunol. 1990 Dec;82(3):429–434. doi: 10.1111/j.1365-2249.1990.tb05466.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ishizaka K., Ishizaka T. Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol. 1970 Jan;6(1):25–42. [PMC free article] [PubMed] [Google Scholar]
  20. Lee W. Y., Sehon A. H. Abrogation of reaginic antibodies with modified allergens. Nature. 1977 Jun 16;267(5612):618–619. doi: 10.1038/267618a0. [DOI] [PubMed] [Google Scholar]
  21. Luo H. Y., Hofstetter H., Banchereau J., Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J Immunol. 1991 Apr 1;146(7):2122–2129. [PubMed] [Google Scholar]
  22. Manning D. D. Induction of temporary IgA deficiency in mice injected with heterologous anti-immunoglobulin heavy chain antisera. J Immunol. 1972 Nov;109(5):1152–1155. [PubMed] [Google Scholar]
  23. Manning D. D., Jutila J. W. Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera. J Exp Med. 1972 Jun 1;135(6):1316–1333. doi: 10.1084/jem.135.6.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Manning D. D., Manning J. K., Reed N. D. Suppression of reaginic antibody (IgE) formation in mice by treatment with anti-mu antiserum. J Exp Med. 1976 Jul 1;144(1):288–292. doi: 10.1084/jem.144.1.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Patterson R., Suszko I. M., McIntire F. C. Polymerized ragweed antigen E. I. Preparation and immunologic studies. J Immunol. 1973 May;110(5):1402–1412. [PubMed] [Google Scholar]
  26. Paul W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991 May 1;77(9):1859–1870. [PubMed] [Google Scholar]
  27. Saxon A., Kurbe-Leamer M., Behle K., Max E. E., Zhang K. Inhibition of human IgE production via Fc epsilon R-II stimulation results from a decrease in the mRNA for secreted but not membrane epsilon H chains. J Immunol. 1991 Dec 1;147(11):4000–4006. [PubMed] [Google Scholar]
  28. Sehon A. H. Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. Prog Allergy. 1982;32:161–202. [PubMed] [Google Scholar]
  29. Vanhove B., Bazin H. Differentiation of membrane IgE+ rat B cells into IgE-secreting cells. Immunology. 1993 Aug;79(4):580–586. [PMC free article] [PubMed] [Google Scholar]
  30. Yuan D. Molecular basis for the inhibition of LPS induced differentiation by anti-immunoglobulin. J Mol Cell Immunol. 1987;3(3):133–144. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES